Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals Ltd (BSE: 539730) announced the acquisition of all assets of Wagr, a pet tech platform, marking its entry into India's pet care industry. The deal is structured as a zero-cash acquisition, where Wagr's founders and investors (including IvyCap Ventures, Inflection Point Ventures, and Stanford Angels) have joined FPL as equity partners rather than taking cash exit. Post-transaction, FPL will hold 78% equity via subsidiary, original Wagr shareholders 20%, and sweat equity 2%. The acquired assets include the Wagr brand, patented pet fitness tracking technology, an app with 140,000+ registered pet parents, a 4.7/5 app rating, 11,000+ completed teleconsultations, and relationships with 70+ pet brands. The marketplace, telemedicine, and veterinary consultation services will be relaunched in Q4 FY2025-26, with all platform sales booked under FPL's revenue. India's pet care market is projected to grow at 22% CAGR from $1 billion in 2021 to $6 billion by 2030.
This is a significant diversification move for FPL beyond its core pharma formulation business into the high-growth pet care and pet tech segment. The zero-cash structure preserves liquidity while bringing in proven technology, an existing user base, and revenue-generating platform. Positive for long-term shareholders if the Q4 FY25-26 relaunch succeeds, though execution risk and integration challenges remain.